Key facts
- It has raised $75.4M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Posco Investment, Partners Investment, iM Investment Partners, UTC Investment, Korea Growth Finance — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Optolane
- ·The full record, as it builds
Funding rounds
No funding rounds for Optolane are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Optolane
Developer of a diagnostic device intended to provide molecular and immunoassay POCT alternatives. The company's semiconductor-integrated In-Vitro Diagnostic device specializes in real-time PCR and Digital PCR through the integration of optical and thermal control systems, enabling individuals to get diseases diagnosed and improve their quality of life.
- Sector
- Healthcare
- HQ
- Yongin, South Korea
- Founded
- 2012
- Employees
- 45
- Website
- optolane.com/
- Ownership
- Privately Held (backing)
Optolane doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optolane shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optolane in its N-PORT filings yet. We sweep new filings monthly.